ArticlePharmaceutics2022
Applicability of RPMI 2650 and Calu-3 Cell Models for Evaluation of Nasal Formulations.
Nadica Sibinovska et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it
ArticlePharmaceutics2022
Nadica Sibinovska et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.